Even though I am a big advocate of Mesoblast, you're overly optimistic IMO with your estimates of our share price at each of those stages you reference..... realistically I think it will be more like $1.50, $2.20 and maybe $4 upon FDA approval (of course assuming we don't receive another CRL).
The only way this reaches $10 with so many SOI now IMO is if Mesoblast make a submission for CHF Accelerated Approval and the FDA accept same for assessment..... the $10 is also heavily contingent on the Remestemcel-L approval happening in the interim..... I hope you're right with your estimates @Hawk70 but I am just not seeing it
GLTAH
MSB Price at posting:
$1.09 Sentiment: Buy Disclosure: Held
(20min delay)